BRAF inhibitors are broadly used for metastatic melanoma with BRAF mutations. Their use results in various cutaneous side effects, such as the development of keratoacanthomas and squamous cell carcinomas. We report a patient with metastatic melanoma ... Sexual Development, 1 month ago
on your WebpageAdd Widget >Get your members hooked!